Ardelyx, Inc. (ARDX) is a leading biotechnology company engaged in the discovery, development, and marketing of medicines to improve patients with cardiorenal and kidney diseases.
Ardelyx, Inc. (ARDX), a biopharmaceutical company, is on a consistent surge in the stock market. In the aftermarket trading session, ARDX stock is trading at $1.22 at
Ardelyx Inc. (ARDX) shares plunged 72.34% in after-hours on Monday, July 19, 2021, and closed the day at $2.13. Earlier in the morning session, ARDX’s
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.